Wireless Type I, II, and III Home Sleep Testing: A More Practical Path Between HST and PSG
“According to Dormotech, DormoVision X was designed to support type 1 (attended) and type II and III studies, offering versatile capabilities for both in-lab and home testing in a single platform. It’s also future-ready—designed with the proposed HST CPT codes in mind. The company will market it as a “full hPSG” (full home polysomnography).”
Sleep medicine has long operated within a clear framework. In-lab polysomnography (PSG) remains the gold standard, while home sleep apnea testing (HSAT) serves a narrower population—primarily uncomplicated OSA cases.
But that leaves a gap.
DormoVision X™ delivers automated, AI-supported analysis with multi-night data capture, enabling more accurate and confident clinical decisions. Designed to integrate into existing workflows, the platform helps sleep programs expand diagnostic capacity without increasing staff burden—supporting higher-quality care at scale.
If your organization is evaluating how to expand diagnostic reach without defaulting every patient to either traditional in-lab PSG or limited-channel home testing alone, Dormotech is worth a closer look.
For further information about Dormotech, please contact:
Abed Nassir, CEO (abed@dormotech.com)
Kyle Hunter, CCO (kyle@dormotech.com)
Featured Articles
Clinical Validations
April 18, 2026
Patient Report: The Effects of Continuous Positive Airway Pressure (CPAP) Therapy on Sleep Quality, Particularly Deep Sleep and Arousals Saar Lanir, PhD, Neuroscientist and sleep researcher at Dormotech Medical. Introduction Sleep-related breathing disorders (SRBDs), including obstructive sleep apnea (OSA), are highly prevalent and associated with substantial morbidity (1). The American Academy of Sleep Medicine […]
View
News
March 31, 2026
The field of sleep medicine is rapidly evolving, and innovation is at the center of that transformation. The American Academy of Sleep Medicine (AASM) continues to spotlight this progress through its Sleep Medicine Disruptors Innovation Award—recognizing technologies that are reshaping how sleep disorders are diagnosed and managed. Read more about the award winners here:https://aasm.org/aasm-sleep-medicine-disruptors-innovation-award-winners/ As […]
View
Research
March 31, 2026
Pediatric sleep disorders, especially sleep apnea, are often underdiagnosed, yet they can have a significant impact on a child’s development, behavior, and long-term health. In a recent article featuring insights from Dr. Asher Tal, the importance of early detection and proper diagnostic pathways is brought into sharp focus. Read the full article here: https://sleepworldmagazine.com/2025/07/28/dormotech-need-for-early-pediatric-sleep-apnea/ One […]
View